We are live on ! Find out more

FPRX

Five Prime Therapeutics, Inc.

FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

71 hedge funds and large institutions have $369M invested in Five Prime Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New

Increased

Maintained

Reduced

Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

157% more capital invested

Capital invested by funds: $144M → $369M (+$226M)

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

73% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 15

13% more funds holding

Funds holding: 63 → 71 (+8)

Holders

Holders Change

Holders Change %

+12.7%

% of All Funds

1.89%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+200%

% of All Funds

0.08%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

1	Point72 Asset Management Stamford, Connecticut	+$9.77M
2	Adage Capital Partners Boston, Massachusetts	+$7.23M
3	BFA BlackRock Fund Advisors San Francisco, California	+$5.45M
4	BIM Bogle Investment Management Newton Lower Falls, Massachusetts	+$3.12M
5	T. Rowe Price Associates Baltimore, Maryland	+$2.87M

Top Sellers

1	O OrbiMed New York	-$12.6M
2	BI BVF Inc San Francisco, California	-$10.9M
3	Goldman Sachs New York	-$7.98M
4	QF QVT Financial New York	-$2.54M
5	NI Numeric Investors Boston, Massachusetts	-$540K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	DCM 26 Driehaus Capital Management Chicago, Illinois	$2.17M	+$1.38M	+80,376	New
27	TC 27 TFS Capital West Chester, Pennsylvania	$2M	+$941K	+54,686	+280%
28	28 Geode Capital Management Boston, Massachusetts	$1.93M	+$312K	+18,114	+34%
29	WMSA 29 Weiss Multi-Strategy Advisers New York	$1.89M	-$344K	-20,000	-22%
30	30 D.E. Shaw & Co New York	$1.88M	+$1.2M	+69,740	New
31	BCM 31 Bridgeway Capital Management Houston, Texas	$1.86M	+$172K	+10,000	+17%
32	32 Bank of New York Mellon New York	$1.73M	-$67.2K	-3,903	-6%
33	TCIM 33 TIAA CREF Investment Management New York	$1.53M	-$111K	-6,467	-10%
34	BIM 34 BlackRock Investment Management Wilmington, Delaware	$1.34M	-$5.49K	-319	-0.6%
35	35 Prudential Financial Newark, New Jersey	$1.18M	+$752K	+43,700	New
36	36 Invesco Atlanta, Georgia	$1.13M	+$717K	+41,683	New
37	NFA 37 Nationwide Fund Advisors Columbus, Ohio	$928K	-$37.2K	-2,160	-6%
38	TRSOTSOK 38 Teachers Retirement System of the State of Kentucky Frankfort, Kentucky	$902K	+$12.7K	+735	+2%
39	39 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$859K	+$2.34K	+136	+0.4%
40	40 California Public Employees Retirement System Sacramento, California	$703K	–	–	–
41	41 Charles Schwab San Francisco, California	$684K	–	–	–
42	TA 42 Teachers Advisors New York	$648K	–	–	–
43	43 Deutsche Bank Frankfurt Am Main Ge, Germany	$640K	+$274K	+15,904	+201%
44	ARTA 44 A.R.T. Advisors New York	$550K	+$351K	+20,385	New
45	BBA 45 Baker Bros. Advisors New York	$535K	–	–	–
46	DC 46 Deere & Company Moline, Illinois	$523K	+$333K	+19,354	New
47	47 TD Asset Management Toronto, Ontario, Canada	$518K	+$330K	+19,200	New
48	CS 48 Credit Suisse Zurich, Switzerland	$514K	+$328K	+19,037	New
49	49 ProShare Advisors Bethesda, Maryland	$485K	+$309K	+17,974	New
50	50 Citadel Advisors Miami, Florida	$472K	+$93.8K	+5,451	+45%

FPRX Hedge Fund Activity: Q4 2014 in Review

71 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2014, worth a combined $369M — up 157% from $144M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new FPRX positions and 8 closed out — a net gain of 10 holders — while 26 added to existing stakes and 15 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $9.77M. The largest seller was OrbiMed, exiting entirely with an estimated $12.6M sold.

71 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2014, up from 63 in Q3 2014.
Funds reported $369M of Five Prime Therapeutics, Inc. stock for Q4 2014, up 157% quarter-over-quarter.
18 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2014 and 8 closed out, a net change of +10 holders.
The largest Five Prime Therapeutics, Inc. buyer in Q4 2014 was Point72 Asset Management, an estimated $9.77M added.
The largest Five Prime Therapeutics, Inc. seller in Q4 2014 was OrbiMed, an estimated $12.6M sold.

Based on aggregated 13F filings for Q4 2014.

Five Prime Therapeutics, Inc. FPRX